Funding and Fees

On this page

What is Cost Recovery?

Cost recovery is a federal government practice. Health Canada charges fees to recoup a portion of costs incurred to deliver regulatory programs and ensure businesses pay their fair share. This is common practice amongst international regulators of health products.

Current Fees

Since the 1990's, the Department has been charging fees for certain services and activities related to the regulation of pharmaceutical, biologic drugs, medical devices and veterinary drugs under the Food and Drugs Act (FDA). These fees apply to such activities as pre-market regulatory review, compliance and enforcement under our inspection program and the ongoing surveillance of products once they are on the market.

Fees as of April 2020

Fees were recently revised under the Cost Recovery Renewal Initiative, and will be implemented April 1, 2020. Selected guidance documents have been updated in advance to reflect the upcoming changes. These documents are posted below for information purposes only and will come into effect as of April 1, 2020.

Human Drugs (as of April 2020)

Medical Devices (as of April 2020)

Veterinary Drugs (as of April 2020)

Additional establishment licensing guidance documents and forms will be shared directly with establishment licence holders by email and posted here by December 31, 2019.

Additional information for those who wish to apply for small business mitigation as of April 1, 2020 will be made available on this page in March 2020.

Inquiries

Questions regarding fee proposals should be directed to the Cost Recovery Policy Inbox at hc.cro-brc.sc@canada.ca.

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: